medigraphic.com
Órgano de Difusión de la Asociación Académica Panamericana de Medicina Familiar A.C.

2023, Number 5

<< Back Next >>

Arch Med Fam 2023; 25 (5)

Early Detection of Diabetic Retinopathy: Experience in a Family medicine unit of Ciudad Madero, Tamaulipas, Mexico

Carrillo-Aguiar LA, Guzmán-Sáenz KJ, González-Pérez B, Salas-Flores R, Álvarez-Rodríguez CK, Romero-Zúñiga JL

Language: Spanish
References: 22
Page: 209-213
PDF size: 201.21 Kb.


ABSTRACT

Objective: To identify the frequency of retinal damage in patients with newly diagnosed DM2 and its timely referral. Methods: A prospective, descriptive, cross-sectional study was carried out at Family Medicine Unit No. 77 of the Mexican Social Security Institute (IMSS), which included patients with recently diagnosed DM2 (‹6 months) who registered retinal changes and who were referred to the ophthalmology outpatient clinic, with prior informed consent. The study was approved by the IMSS Research Ethics Committee. Results: a total of 63 patients were included, the frequency of retinal damage found was 28.6%. Direct ophthalmoscopy was performed in 36.5% of the patients, timely referral was 28.5%. Counter-referral revealed the following distribution of DR: mild non-proliferative retinopathy (PNR) in 3.2%, moderate PNR in 3.2%, severe PNR in only one case (1.6%), while proliferative retinopathy was observed in 3.2% of the population. Conclusion: regular examinations in newly diagnosed DM2 patients are effective for detection and monitoring of asymptomatic DR. Our data suggest that screening for DR should be performed at the time of DM2 diagnosis and annually or every two years thereafter.


REFERENCES

  1. Wong Márquez LF, García Torres O, Cruz Morales RA,Álvarez Villaseñor AS. Control metabólico de pacientescon diabetes mellitus tipo 2: comparación entreDiabetimss y consultorios de medicina familiar. AtenciónFamiliar. 2021 Dec 6;29(1):41. doi: https://doi.org/10.22201/fm.14058871p.2022.1.81188

  2. Instituto Nacional de Salud Pública. Encuesta Nacionalde Salud y Nutrición de Medio Camino 2016. 2016

  3. Álvarez Torres M, Álvarez Aguilar C, Gómez García A.Evaluación de supervivencia en el adulto mayor con diabetesmellitus de acuerdo con la Guía de Práctica Clínica.Atención Familiar. 2022 Jun 28;29(3):154. doi: https://doi.org/10.22201/fm.14058871p.2022.3.82833

  4. Ibáñez Franco EJ, Fretes Ovelar AMC, Duarte ArévalosLE, Giménez Vázquez FDJ, Olmedo Mercado EF, FigueredoMartínez HJ, et al. Frequency of chronic complicationsin patients with type 2 diabetes mellitus in athird level hospital. Rev virtual Soc Parag Med Int. 2022Mar 30;9(1):45-54. doi: https://doi.org/10.18004/rvspmi/2312-3893/2022.09.01.45

  5. Jammal H, Khader Y, Alkhatib S, Abujbara M, AlomariM, Ajlouni K. Diabetic retinopathy in patientswith newly diagnosed type 2 diabetes mellitus inJordan: Prevalence and associated factors. Journalof Diabetes. 2013 Jun;5(2):172-9. doi: https://doi.org/10.1111/1753-0407.12015

  6. Pineda Sarabia C, Zarco Vite XJ, Ruiz Morales ML. Retinopatíadiabética, una complicación descuidada.Atención Familiar. 2018 Apr 2;25(2):83. doi: https://doi.org/10.22201/facmed.14058871p.2018.2.63563

  7. Yin L, Zhang D, Ren Q, Su X, Sun Z. Prevalence and riskfactors of diabetic retinopathy in diabetic patients.Medicine. 2020 Feb;99(9):e19236. doi: https://doi.org/10.1097/MD.0000000000019236

  8. Jiménez-Báez MV, Márquez-González H, Bárcenas-ContrerasR, Morales-Montoya C, Espinosa-García LF.Early diagnosis of diabetic retinopathy in primarycare. Colomb Med. 2015; 46(1): 14-8. doi: https://doi.org/10.1111/1753-0407.12015

  9. Vivas-Giraldo JP, Bravo-Acosta JD. Caracterizaciónde la retinopatía diabética en un programa de tamizaciónen Medellín, Colombia, en el año 2018. RMO.2021 May 25;95(3). doi: https://doi.org/10.24875/rmo.m21000169

  10. Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE.The Wisconsin Epidemiologic Study of Diabetic RetinopathyXXIII: The Twenty-five-Year Incidence of MacularEdema in Persons with Type 1 Diabetes. Ophthalmology.2009 Mar;116(3):497-503. doi: https://doi.org/10.1016/j.ophtha.2008.10.016

  11. Lechner J, O’Leary OE, Stitt AW. The pathology associatedwith diabetic retinopathy. Vision Research.2017 Oct;139:7-14. doi: https://doi.org/10.1016/j.visres.2017.04.003

  12. Mayya V, Kamath S․ S, Kulkarni U. Automated microaneurysmsdetection for early diagnosis of diabetic retinopathy:A Comprehensive review. Computer Methodsand Programs in Biomedicine Update. 2021;1:100013.doi: https://doi.org/10.1016/j.cmpbup.2021.100013

  13. Asociación Panamericana de Oftalmología. Actualizaciónde la Guía Clínica de Retinopatía Diabética. 2016.

  14. ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, BrownFM, Bruemmer D, et al. 2. Classification and Diagnosisof Diabetes: Standards of Care in Diabetes—2023.Diabetes Care. 2023 Jan 1;46(Supplement_1):S19-S40.doi: https://doi.org/10.2337/dc23-S002

  15. Ting DSW, Cheung GCM, Wong TY. Diabetic retinopathy:global prevalence, major risk factors, screening practicesand public health challenges: a review. Clinical &Experimental Ophthalmology. 2016 May;44(4):260-77.doi: https://doi.org/10.1111/ceo.12696

  16. Kostev K, Rathmann W. Diabetic retinopathy at diagnosisof type 2 diabetes in the UK: a database analysis.Diabetologia. 2013 Jan;56(1):109-11. doi: https://doi.org/10.1007/s00125-012-2742-7

  17. Shah S, Feher M, McGovern A, Sherlock J, Whyte MB,Munro N, et al. Diabetic retinopathy in newly diagnosedType 2 diabetes mellitus: Prevalence and predictorsof progression; a national primary networkstudy. Diabetes Research and Clinical Practice. 2021May;175:108776. doi: https://doi.org/10.1016/j.diabres.2021.108776

  18. Kohner EM, Stratton IM, Aldington SJ, Turner RC, MatthewsDR. Microaneurysms in the development ofdiabetic retinopathy (UKPDS 42). Diabetologia. 1999Aug 19;42(9):1107-12. doi: https://doi.org/10.1007/s001250051278

  19. Looker HC, Nyangoma SO, Cromie D, Olson JA, LeeseGP, Black M, et al. Diabetic retinopathy at diagnosisof type 2 diabetes in Scotland. Diabetologia. 2012Sep;55(9):2335-42. doi: https://doi.org/10.1007/s00125-012-2596-z

  20. Chung Y, Xu T, Tung T, Chen M, Chen P. Early Screeningfor Diabetic Retinopathy in Newly Diagnosed Type 2Diabetes and Its Effectiveness in Terms of Morbidityand Clinical Treatment: A Nationwide Population-BasedCohort. Front Public Health. 2022 Apr 26;10. doi:https://doi.org/10.3389/fpubh.2022.771862

  21. Olafsdottir E, Andersson DKG, Dedorsson I, StefánssonE. The prevalence of retinopathy in subjects with andwithout type 2 diabetes mellitus. Acta Ophthalmologica.2014 Mar;92(2):133-7. doi: https://doi.org/10.1111/aos.12095

  22. Namperumalsamy P, Kim R, Vignesh TP, Nithya N,Royes J, Gijo T, et al. Prevalence and risk factors fordiabetic retinopathy: a population-based assessmentfrom Theni District, south India. Postgraduate MedicalJournal. 2009 Dec 1;85(1010):643-8. doi: https://doi.org/10.1136/bjo.2008.147934




2020     |     www.medigraphic.com